Arthro Kinetics Biotechnology GmbH: We develop, manufacture and distribute medical implants based on a proprietary and unique 3D Biomatrix from collagen type 1, which functions as a neutral organ scaffold for different types of cells. Today, our unique Matrix provides a proven three-dimensional cultivation environment for products and procedures to repair, to regenerate and to restore natural tissue function. With its applications, it proofs an extraordinary pathway since 2004.
Arthro Kinetics Biotechnology GmbH: We develop, manufacture and distribute medical implants based on a proprietary and unique 3D Biomatrix from collagen type 1, which functions as a neutral organ scaffold for different types of cells. Today, our unique Matrix provides a proven three-dimensional cultivation environment for products and procedures to repair, to regenerate and to restore natural tissue function. With its applications, it proofs an extraordinary pathway since 2004.
Austria Wirtschaftsservice GmbH (aws) is the promotional bank of the Austrian federal government. It supports companies in implementing their innovative projects by offering soft loans, grants and guarantees, particularly in cases where the funds required cannot be obtained sufficiently through alternative funding. LISA - Life Science Austria run by Austria Wirtschaftsservice aims at positioning Austria as a leading life science location offering a variety of support measures. Organized through regional life science clusters, LISA represents companies in the therapeutic, medical technology and diagnostic sectors as well as providers of enabling technologies and related service companies located in the following regions: ecoplus (Lower Austria), Medical Technology Cluster (Upper Austria), LISAvienna (Vienna), human.technology.styria (Styria), Standortagentur Tirol (Tyrol), Innovation Salzburg (Salzburg).
Serviceprovider for pharmaceutical industry, quality management (ISO9001, ISO13485, ISO15224, ISO14971), non-interventional studies, data privacy (GDPR), validation, qualification
We help ambitious clients with scaling and growth through digital success.
M-B-V-C offers expert venture management and strategy consulting for entrepreneurs and executives in tech- and innovation-driven startups and intrapreneurial business ventures towards company success.
Unlock efficiency in your exploration and exploitation activities through expert advice on your strategy, business plan, team building, fundraising, business development, scaling and company development towards successful commercialisation.
#HelpingVenturesTakeFlight
#venture #biotech #biopharma #deeptech #innovation #commercialisation #success #exploration #exploitation #ambidexterity #m-b-v-c
Die Confideck-Software ist auf die Automatisierung von Compliance-Prozessen zugeschnitten und unterstützt MedTech-Hersteller bei der Einhaltung von MDR/IVDR und FDA sowie bei der effizienten Verwaltung der technischen Dokumentation.
The objective of Health Hub Tirol, an initiative of the State of Tyrol, is to promote innovation in the fields of life sciences, medical technology, e-health, pharmaceuticals and biotechnology and to further enhance Tyrol’s profile as an internationally recognised healthcare industry location boasting many successful companies. The initiative aims to facilitate not only the founding of life science companies in Tyrol, but also to encourage businesses to locate here and/or to establish and develop their business model in the region.
medupha ist Experte für healthcare Marktforschung. Mit einem Team aus Pharma-/Healthcare Expert:innen, Psycholog:innen und Marktforschungsexpert:innen setzt das Institut Ärztebefragungen, Patientenumfragen und Bevölkerungsumfragen für verschiedene stakeholder im Gesundheitswesen um (Pharma, Medizintechnik, Biotech, öffentlicher Sektor, Gesundheitsdienstleister, .. ). Das Institut analysiert Märkte, Therapiegewohnheiten, Patientenmeinungen und hat 50 Jahre Expertise in Methodik, Analyse und Beratung. Zwei qualifizierte eigene Befragungspools (Ärzte, Patient:innen - www.patietenstimme.eu) garantieren Zugang zu relevanten Zielgruppen.
The objective of Health Hub Tirol, an initiative of the State of Tyrol, is to promote innovation in the fields of life sciences, medical technology, e-health, pharmaceuticals and biotechnology and to further enhance Tyrol’s profile as an internationally recognised healthcare industry location boasting many successful companies. The initiative aims to facilitate not only the founding of life science companies in Tyrol, but also to encourage businesses to locate here and/or to establish and develop their business model in the region.
Karl Landsteiner University of Health Sciences (KL Krems) at Campus Krems offers a modern, demand-oriented education and continuing education in medicine and psychology as well as a PhD programme in Mental Health and Neuroscience. Research at KL Krems is marked by scientific collaboration between different departments from key fields of health sciences, medicine and psychology. The three university hospitals in Krems, St. Pölten and Tulln and the MedAustron Ion Therapy and Research Centre in Wiener Neustadt guarantee clinical teaching and research of the highest quality.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
bespark*bio is a privately held biotech start-up, offering bespoke process development for novel biotherapeutics such as viral vectors, bionanoparticles (VLPs and exosomes), and biologics (monoclonal antibodies).
We deliver robust, phase-appropriate and scalable processes, enhance development efficiency and significantly de-risk development activities for our clients.
The European Institute of Innovation & Technology (EIT) is an independent institution of the European Union, founded in 2008 to promote innovation and entrepreneurship across Europe. Since 2014, the network initiative has also been active in the field of health in Europe. EIT Health is currently working with around 130 members in a "public-private partnership" to find solutions to the major healthcare challenges of our time. Leading companies, public institutions as well as renowned universities and research institutions are working together with start-ups and SMEs in innovative programmes and projects to develop new products and services that promote a sustainable health economy in Europe. The aim of EIT Health is to close the innovation gap in the life science sector.
EIT Health Austria is one of a total of eight EIT Health centres in Europe and currently supports 15 members from industry, research and education in Austria, including Boehringer Ingelheim, Med Uni Graz, the Ludwig Boltzmann Gesellschaft, as well as start-ups and SMEs in the development of groundbreaking innovations in healthcare. With the "HealthGateway.Austria" project, EIT Health Austria also operates an innovation laboratory in Vienna funded by the FFG, which increasingly integrates Austrian companies and organisations in the life science sector into the activities of EIT Health.